Get the Stockscreener App
8.055
8.08%
-0.985
Wave Life Sciences Ltd stock is traded at $8.055, with a volume of 4.22M.
It is down -8.08% in the last 24 hours and up +16.22% over the past month.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$9.04
Open:
$8.9
24h Volume:
4.22M
Relative Volume:
1.71
Market Cap:
$1.32B
Revenue:
$93.95M
Net Income/Loss:
$-129.87M
P/E Ratio:
-8.95
EPS:
-0.9
Net Cash Flow:
$-202.88M
1W Performance:
+9.06%
1M Performance:
+16.22%
6M Performance:
+2.59%
1Y Performance:
-39.91%
1-Day Range:
$8.20
$9.13
1-Week Range:
$7.34
$9.75
52-Week Range:
$5.28
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.31 | 1.44B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-04-25 | Initiated | Canaccord Genuity | Buy |
| Jul-28-25 | Initiated | Oppenheimer | Outperform |
| Jul-16-25 | Initiated | Citigroup | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-25 | Initiated | Wedbush | Outperform |
| Feb-25-25 | Initiated | Jefferies | Buy |
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
Wave Life Sciences (NASDAQ: WVE) sets Q3 results webcast for Nov 10 with analyst Q&A - Stock Titan
What insider trading reveals about Wave Life Sciences Ltd. stockEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Is Wave Life Sciences Ltd. meeting your algorithmic filter criteriaPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
How Wave Life Sciences Ltd. stock compares to market leadersEarnings Beat & Intraday High Probability Alerts - newser.com
Can Wave Life Sciences Ltd. rally from current levels2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com
Why Wave Life Sciences Ltd. stock appeals to analysts2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Wave Life Sciences (WVE) HD Program Unaffected by uniQure's FDA Hurdles - GuruFocus
Wave Life Sciences Hits Day High with 8.92% Surge in Stock Price - Markets Mojo
Will Wave Life Sciences Ltd. (1U5) stock hit analyst forecastsBull Run & Reliable Volume Spike Trade Alerts - newser.com
Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturnsWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Can Wave Life Sciences Ltd. recover in the next quarterPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsGlobal Markets & Low Risk High Reward Trade Ideas - newser.com
Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Candlestick signals on Wave Life Sciences Ltd. stock todayOil Prices & Daily Momentum Trading Reports - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitorsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Can Wave Life Sciences Ltd. stock deliver sustainable ROE2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade
Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo
Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com
Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena
Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat
Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st
Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN
WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan
Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Wave Life Sciences Ltd Stock (WVE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):